LUMEXA IMAGING HOLDINGS INC
LMRINASDAQTrading Snapshot
- Day Range
- $10.12 – $10.34
- 52-Week Range
- $6.45 – $19.45
- Volume
- $2.78B
- Avg Volume
- $1.86B
- Shares Outstanding
- 96.1M
- Next Earnings
- Nov 5, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.02B
- Last Q Revenue
- $264M
- P/E Ratio
- —
- P/S Ratio
- 0.6x
- EPS (TTM)
- $-0.43
- Dividend Yield
- —
- Dilution (1yr)
- −20.3%
Why Investors Own LMRI
- ✓High-growth profile — revenue up +3.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 29% gross margin and 21% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
LUMEXA IMAGING HOLDINGS INC
LMRI
StockOtter · stockotter.spaceAbout LUMEXA IMAGING HOLDINGS INC
Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) Receives Average Recommendation of “Buy” from Analysts
Shares of Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI - Get Free Report) have earned an average recommendation of "Buy" from the five analysts that are currently covering the company, MarketBeat.com reports. One research
Lumexa Imaging Holdings, Inc. $LMRI Shares Purchased by Squarepoint Ops LLC
Squarepoint Ops LLC grew its position in shares of Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI) by 506.9% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned
Lumexa (LMRI) Upgraded to Buy: Here's What You Should Know
Lumexa (LMRI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BlackRock Inc. Takes $15.77 Million Position in Lumexa Imaging Holdings, Inc. $LMRI
BlackRock Inc. bought a new position in shares of Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla,
Wall Street Analysts See a 36.88% Upside in Lumexa (LMRI): Can the Stock Really Move This High?
The consensus price target hints at a 36.9% upside potential for Lumexa (LMRI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean